|
1
|
Njei B, Rotman Y, Ditah I and Lim JK:
Emerging trends in hepatocellular carcinoma incidence and
mortality. Hepatology. 61:191–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ulahannan SV, Duffy AG, McNeel TS, Kish
JK, Dickie LA, Rahma OE, McGlynn KA, Greten TF and Altekruse SF:
Earlier presentation and application of curative treatments in
hepatocellular carcinoma. Hepatology. 60:1637–1644. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coskun E, von der Heide EK, Schlee C,
Kühnl A, Gökbuget N, Hoelzer D, Hofmann WK, Thiel E and Baldus CD:
The role of microRNA-196a and microRNA-196b as ERG regulators in
acute myeloid leukemia and acute T-lymphoblastic leukemia. Leuk
Res. 35:208–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu X, Ling Q, Wang J, Xie H, Wei X, Lu D,
Hu Q, Zhang X, Wu L, Zhou L and Zheng S: Donor miR-196a-2
polymorphism is associated with hepatocellular carcinoma recurrence
after liver transplantation in a Han Chinese population. Int J
Cancer. 138:620–629. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsai MM, Wang CS, Tsai CY, Huang CG, Lee
KF, Huang HW, Lin YH, Chi HC, Kuo LM, Lu PH and Lin KH: Circulating
microRNA-196a/b are novel biomarkers associated with metastatic
gastric cancer. Eur J Cancer. 64:137–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Huang H, Chen P, He M, Li Y,
Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, et al: miR-196b
directly targets both HOXA9/MEIS1 oncogenes and FAS tumour
suppressor in MLL-rearranged leukaemia. Nat Commun. 3:6882012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XD, Li ZG, Song XX and Liu CF: A
variant in microRNA-196a2 is associated with susceptibility to
hepatocellular carcinoma in Chinese patients with cirrhosis.
Pathology. 42:669–673. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li W, Chang J, Tong D, Peng J, Huang D,
Guo W, Zhang W and Li J: Differential microRNA expression profiling
in primary tumors and matched liver metastasis of patients with
colorectal cancer. Oncotarget. 8:35783–35791. 2017.PubMed/NCBI
|
|
10
|
Lu YC, Chang JT, Liao CT, Kang CJ, Huang
SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, et al:
OncomiR-196 promotes an invasive phenotype in oral cancer through
the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 13:2182014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen J, Wang S, Zhang YJ, Kappil MA, Chen
Wu H, Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, et al:
Genome-wide aberrant DNA methylation of microRNA host genes in
hepatocellular carcinoma. Epigenetics. 7:1230–1237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El-Guendy NM, Helwa R, El-Halawany MS,
Abdel Rahman Ali S, Tantawy Aly M, Hasan Alieldin N, Fouad SA,
Saeid H and Abdel-Wahab AH: The liver MicroRNA expression profiles
associated with chronic hepatitis C virus (HCV) genotype-4
infection: A preliminary study. Hepat Mon. 16:e338812016.PubMed/NCBI
|
|
13
|
Chang W, Zhang L, Xian Y and Yu Z:
MicroRNA-33a promotes cell proliferation and inhibits apoptosis by
targeting PPARα in human hepatocellular carcinoma. Exp Ther Med.
13:2507–2514. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendonsa AM, VanSaun MN, Ustione A, Piston
DW, Fingleton BM and Gorden DL: Host and tumor derived MMP13
regulate extravasation and establishment of colorectal metastases
in the liver. Mol Cancer. 14:492015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anwar SL and Lehmann U: MicroRNAs:
Emerging novel clinical biomarkers for hepatocellular carcinomas. J
Clin Med. 4:1631–1650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guan Y, Mizoguchi M, Yoshimoto K, Hata N,
Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, et al:
MiRNA-196 is upregulated in glioblastoma but not in anaplastic
astrocytoma and has prognostic significance. Clin Cancer Res.
16:4289–4297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma R, Yan W, Zhang G, Lv H, Liu Z, Fang F,
Zhang W, Zhang J, Tao T, You Y, et al: Upregulation of miR-196b
confers a poor prognosis in glioblastoma patients via inducing a
proliferative phenotype. PLoS One. 7:e380962012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanno S, Nosho K, Ishigami K, Yamamoto I,
Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S,
et al: MicroRNA-196b is an independent prognostic biomarker in
patients with pancreatic cancer. Carcinogenesis. 38:425–431. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Yao C, Li H, Wang G and He X:
Combined elevation of microRNA-196a and microRNA-196b in sera
predicts unfavorable prognosis in patients with osteosarcomas. Int
J Mol Sci. 15:6544–6555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong CC, Kai AK and Ng IO: The impact of
hypoxia in hepatocellular carcinoma metastasis. Front Med. 8:33–41.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y
and Liu Q: Fibulin-5 inhibits hepatocellular carcinoma cell
migration and invasion by down-regulating matrix
metalloproteinase-7 expression. BMC Cancer. 14:9382014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li CY, Liang GY, Yao WZ, Sui J, Shen X,
Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, et al: Identification
and functional characterization of microRNAs reveal a potential
role in gastric cancer progression. Clin Transl Oncol. 19:162–172.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Zhang M, Chen H, Dong Z, Ganapathy
V, Thangaraju M and Huang S: Ratio of miR-196s to HOXC8 messenger
RNA correlates with breast cancer cell migration and metastasis.
Cancer Res. 70:7894–7904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stiegelbauer V, Vychytilova-Faltejskova P,
Karbiener M, Pehserl AM, Reicher A, Resel M, Heitzer E, Ivan C,
Bullock M, Ling H, et al: MicroRNA-196b-5p regulates colorectal
cancer cell migration and metastases through interaction of HOXB7
and GALNT5. Clin Cancer Res. 23:5255–5266. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cuiffo BG, Campagne A, Bell GW, Lembo A,
Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al:
MSC-regulated microRNAs converge on the transcription factor FOXP2
and promote breast cancer metastasis. Cell Stem Cell. 15:762–774.
2014. View Article : Google Scholar : PubMed/NCBI
|
